Authors
Latest:
Dr. Magi-Galluzzi on Preventing Overtreatment of Prostate CancerCristina Magi-Galluzzi, MD, PhD, discusses the importance of properly diagnosing patients with prostate cancer to avoid overtreatment.
Latest:
Dr. Rodriguez on Systemic Therapy in Salivary Gland CancerCristina P. Rodriguez, MD, hematology oncologist, University of Washington School of Medicine in Seattle, discusses the emerging role of systemic therapy for patients with salivary gland cancer.
Latest:
Effective Management and Prevention of Neratinib-Induced DiarrheaSafety data from clinical trials suggest that a prophylactic regimen reduces both the severity and duration of neratinib-associated diarrhea.
Latest:
Dr. Pettaway on the Prevalence of Germline Mutations in Diverse Populations With Prostate CancerCurtis A. Pettaway, MD, professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the prevalence of germline mutations in diverse populations with prostate cancer.
Latest:
Dr. Sears on Bacteria Influencing Development of Colon CancerCynthia L. Sears, MD, professor of Medicine, Johns Hopkins University School of Medicine, member of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, discusses bacteria possibly influencing the development of colon cancer.
Latest:
Dr Ma on Interim Efficacy and Safety Data With RLY-2608 in PI3Kα-Mutant HR+/HER2– Breast CancerCynthia X. Ma, MD, PhD, discusses positive interim data from the phase 1 ReDiscover trial in PI3Kα-mutated HR-positive, HER2-negative breast cancer.
Latest:
Dr. Sears on Ongoing Research of Microbiota in CRCCynthia L. Sears, MD, professor of Medicine, at Johns Hopkins University School of Medicine, member of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, discusses ongoing research of microbiota for patients with colorectal cancer (CRC).
Latest:
UVA Screening Program Seeks to Get Ahead of Colorectal CancerApproximately 1 of every 20 Americans will be diagnosed with colorectal cancer at some point in their life, and the American Cancer Society estimates that most colorectal cancer deaths can be prevented by screening.
Latest:
Bone Marrow Biopsy Simulation Training for FellowsA bone marrow aspirate and biopsy is the single most common procedure that hematologists and oncologists carry out day in and day out throughout their career.
Latest:
How the Drive to Connect the Oncology Community Built an Educational Podcast Platform: With D. Ross Camidge, MD, PhD; and Rahul Gosain, MD, MBADrs Camidge and Gosain discuss how Dr Gosain harnessed social media to create a podcast with practice updates for up-and-coming oncology professionals.
Latest:
Dr. Camidge on Toxicities of Sunvozertinib in EGFR Exon 20–Mutated NSCLCRoss Camidge, MD, PhD, discusses toxicities observed with sunvozertinib in EGFR exon 20–mutated non–small cell lung cancer.
Latest:
Immune Checkpoint Inhibitors Hold Promise In GlioblastomaThere are reasons to suggest that immune checkpoint inhibitors may be successful against central nervous system tumors, including glioblastoma.
Latest:
Dr. Laber on the PRODIGE 35-PANOPTIMOX Trial in Metastatic Pancreatic CancerDamian Laber, MD, hematologist/oncologist, senior member, Moffitt Cancer Center, discusses the PRODIGE 35-PANOPTIMOX trial in metastatic pancreatic cancer.
Latest:
Dr Reed on the Investigation of Trastuzumab Deruxtecan in HER2+ OsteosarcomaDamon R. Reed, MD, discusses a phase 2 study of fam-trastuzumab deruxtecan-nxki in adolescent and young adult patients with recurrent HER2-positive osteosarcoma.
Latest:
Dr. Beachler on HPV Vaccine Efficacy Among Previously Exposed IndividualsDan Beachler, MD, fellow at the National Cancer Institute, discusses the efficacy of the HPV vaccine on individuals who have been previously exposed to the virus compared to those who have not.
Latest:
Specialty Pharmacy: Build, Buy, or PartnerFor oncology practices that want to expand specialty pharmacy services on behalf of their patients, should they build, buy, or partner?
Latest:
Advanced Prostate Cancer: Remaining ChallengesExperts discuss challenges and unmet needs in men with advanced prostate cancer who are undergoing treatment with androgen deprivation therapy.
Latest:
Dr. Raz on the Effects of COVID-19 on Lung Cancer ScreeningDan J. Raz, MAS, MD, discusses the effects of COVID-19 on lung cancer screening.
Latest:
Payment Assistance for Patients With CancerDan Klein, President and CEO of Patient Access Network Foundation, discusses payment assistance for patients with cancer.
Latest:
Can New Technologies Be Used to Predict Treatment Response in Cancer Patients?The next leap forward in cancer treatment will see physicians tailoring treatments based on patients' individualized tumor profiles.
Latest:
Dr. Zandberg on Biomarker Development in Head and Neck CancerDan Zandberg, MD, assistant professor of medicine, the University of Maryland School of Medicine, discusses biomarker development in patients with head and neck cancer.
